Inventor
SCOTT MARK D
US17 patents
⚠️ This page may combine multiple inventors who share the name “SCOTT MARK D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CANADIAN BLOOD SERVICES
8 patentsUS7964339B2Jun 21, 2011
Cold storage of modified platelets
CANADIAN BLOOD SERVICES3 citations61
US11007221B2May 18, 2021
Acellular pro-inflammatory compositions, process for making same and methods of using same
CANADIAN BLOOD SERVICES0 citations48
US10188681B2Jan 29, 2019
Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes
CANADIAN BLOOD SERVICES0 citations48
US10039786B2Aug 7, 2018
Acellular pro-tolerogenic compositions and process for making same
CANADIAN BLOOD SERVICES0 citations48
US10039787B2Aug 7, 2018
Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases
CANADIAN BLOOD SERVICES0 citations48
US10039788B2Aug 7, 2018
Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection
CANADIAN BLOOD SERVICES0 citations48
US9498496B2Nov 22, 2016
Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes
CANADIAN BLOOD SERVICES0 citations48
US10561685B2Feb 18, 2020
Combination therapy of acellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system
CANADIAN BLOOD SERVICES0 citations38
ALBANY MEDICAL COLLEGE
5 patentsUS5908624AJun 1, 1999
Antigenic modulation of cells
ALBANY MEDICAL COLLEGE44 citations92
US8007784B1Aug 30, 2011
Antigenic modulation of cells
ALBANY MEDICAL COLLEGE13 citations84
US6699465B2Mar 2, 2004
Covalent attachment of polymer to cell to prevent virus bonding to receptor
ALBANY MEDICAL COLLEGE12 citations73
US6555656B2Apr 29, 2003
Covalent modification of abnormal prion protein
ALBANY MEDICAL COLLEGE7 citations73
US6524586B2Feb 25, 2003
Enhancement of oligomeric viral immunogenicity
ALBANY MEDICAL COLLEGE4 citations62